DA DALT, LORENZO
DA DALT, LORENZO
Dipartimento di Scienze Farmacologiche e Biomolecolari
Cameroonian spice extracts modulate molecular mechanisms relevant to cardiometabolic diseases in sw 872 human liposarcoma cells
2021 A.P. Atchan Nwakiban, A. Passarelli, L. Da Dalt, C. Olivieri, T.N. Demirci, S. Piazza, E. Sangiovanni, E. Carpentier-maguire, G. Martinelli, S.T. Shivashankara, U.V. Manjappara, A.D. Tchamgoue, G.A. Agbor, J.-. Kuiate, M. Daglia, M. Dell'Agli, P. Magni
Cholesterol metabolism, pancreatic β-cell function and diabetes
2019 C. Perego, L. Da Dalt, A. Pirillo, A. Galli, A.L. Catapano, G.D. Norata
Genetically determined hypercholesterolaemia results into premature leucocyte telomere length shortening and reduced haematopoietic precursors
2022 A. Baragetti, F. Bonacina, L. Da Dalt, A. Moregola, V. Zampoleri, F. Pellegatta, L. Grigore, A. Pirillo, R. Spina, A.B. Cefalù, M. Averna, G.D. Norata, A.L. Catapano
Impact of hepatic or pancreatic tissue selective PCSK9-deficiency on pancreas morphology, insulin release and glucose metabolism.
2020 C. Perego, A. Marku, L. Da Dalt, A. Galli, A. Catapano, D. Norata
IMPACT OF PCSK9 ON EXTRAHEPATIC TISSUES
2021 L. DA DALT
Impatto della produzione epatica e pancreatica di PCSK9 sull'omeostasi glucidica
2020 A. Marku, L. Da Dalt, A. Galli, A.L. Catapano, D.G. Norata, C. Perego
Lipid accumulation impairs lysosomal acid lipase activity in hepatocytes : evidence in NAFLD patients and cell cultures
2019 M. Gomaraschi, A.L. Fracanzani, P. Dongiovanni, C. Pavanello, E. Giorgio, L. Da Dalt, G.D. Norata, L. Calabresi, D. Consonni, R. Lombardi, A. Branchi, S. Fargion
Mannose Receptor Deficiency Impacts Bone Marrow and Circulating Immune Cells during High Fat Diet Induced Obesity
2022 J. Nour, A. Moregola, M. Svecla, L. Da Dalt, R. Bellini, O. Neyrolles, G.P. Fadini, Y. Rombouts, M. Albiero, F. Bonacina, G.D. Norata
Metabolic adaptations of cells at the vascular-immune interface during atherosclerosis
2021 F. Bonacina, L. Da Dalt, A.L. Catapano, G.D. Norata
Myeloid apolipoprotein E controls dendritic cell antigen presentation and T cell activation
2018 F. Bonacina, D. Coe, G. Wang, M.P. Longhi, A. Baragetti, A. Moregola, K. Garlaschelli, P. Uboldi, F. Pellegatta, L. Grigore, L. DA DALT, A. Annoni, S. Gregori, Q. Xiao, D. Caruso, N. Mitro, A.L. Catapano, F.M. Marelli-Berg, G.D. Norata
Pancreatic PCSK9 controls the organization of the β-cell secretory pathway via LDLR-cholesterol axis
2022 A. Marku, L. Da Dalt, A. Galli, N. Dule, P. Corsetto, A.M. Rizzo, A. Moregola, P. Uboldi, F. Bonacina, P. Marciani, M. Castagna, A.L. Catapano, G.D. Norata, C. Perego
PCSK9 deficiency reduces insulin secretion and promotes glucose intolerance: the role of the low-density lipoprotein receptor
2019 L. Da Dalt, M. Ruscica, F. Bonacina, G. Balzarotti, A. Dhyani, E. Di Cairano, A. Baragetti, L. Arnaboldi, S. De Metrio, F. Pellegatta, L. Grigore, M. Botta, C. Macchi, P. Uboldi, C. Perego, A.L. Catapano, G.D. Norata
PCSK9 deficiency rewires heart metabolism and drives heart failure with preserved ejection fraction
2021 L. Da Dalt, L. Castiglioni, A. Baragetti, M. Audano, M. Svecla, F. Bonacina, S. Pedretti, P. Uboldi, P. Benzoni, F. Giannetti, A. Barbuti, F. Pellegatta, S. Indino, E. Donetti, L. Sironi, N. Mitro, A.L. Catapano, G.D. Norata
Rivaroxaban improves vascular response in LPS-induced acute inflammation in experimental models
2020 A. Daci, L. Da Dalt, R. Alaj, S. Shurdhiqi, B. Neziri, R. Ferizi, G.D. Norata, S. Krasniqi